Table III.
Level of ASMR | Criteria |
---|---|
I | Major innovation: innovative product with substantial therapeutic benefit |
II | Important improvement in terms of therapeutic efficacy and/or reducing side effects |
III | Moderate improvement in terms of therapeutic efficacy and/or utility |
IV | Minor improvement in terms of therapeutic efficacy and/or reducing side effects |
V | No improvement over existing options but still can be recommended for reimbursement (e.g., generic drugs and me-too drugs) |